Delivery Order SPE2DB22D1202-SPE2DB23FHVH3
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $17
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8,120 delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The firm fixed price order is being performed in Conshohocken, Pennsylvania under the Department of Defense's pharmaceutical supply chain management program. No subcontractors or set aside designations were specified. Amerisourcebergen will fulfill the order for antibiotic medication from July 27 to July 28, 2023 to support the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $24,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the antibiotic medication to a location in Conshohocken, Pennsylvania by August 7, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The delivery order...
- The Defense Logistics Agency awarded a $193,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 400-57 MG/5 ML SUSP 100ML. As a major pharmaceutical supplier to the Department of Defense, Amerisourcebergen will deliver antibiotic medications to a Defense Logistics Agency location in Conshohocken, Pennsylvania by July 12, 2023 to support DLA procurement programs. No set aside designation or subcontractors were identified for this short-term order under the...
- The Defense Logistics Agency awarded a $16,240 delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle and calls for delivery to a location in Conshohocken, Pennsylvania by August 28, 2023. As a leading provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will deliver the requested antibiotic...
- The Defense Logistics Agency awarded a $24,360 delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide antibiotic medication to support Department of Defense operations. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 3rd to August 4th, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a $752.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 4561935301 AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The single day contract has a period of performance from August 24, 2023 through August 25, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $368,000 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561412534, described as AMOX-CLAV 200-28.5 MG/5 ML SUS 100ML. The single-day contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the solicitation or any overarching contracts under which this delivery order was issued. The award utilizes DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $50,060 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561772924 AMOX-CLAV 250-62.5 MG/5 ML SUS 100ML. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location between August 10-11, 2023. The delivery order was issued under an existing DLA contract vehicle to supply the antibiotic medication at the stated dosage for use in DOD...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $16,240 to Amerisourcebergen Drug Corporation for 4561522549 AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. Place of performance will be in Conshohocken, Pennsylvania over one day in July 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a commonly prescribed antibiotic suspension supports the Agency's mission to provide critical medicines...
- The Defense Logistics Agency awarded a $20,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the antibiotic medication from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by September 28, 2023. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the U.S. military and...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHVH3Delivery Order
The Defense Logistics Agency awarded a $16,680 delivery order to Amerisourcebergen Drug Corporation for AMOX-CLAV 400-57 MG/5 ML SUSP 100ML. The firm fixed price order is being performed in Conshohocken, Pennsylvania under DLA's pharmaceuticals schedule contract vehicle from July 14-17, 2023. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the antibiotic medication to support the Defense Department's health services programs. No subcontractors or set-aside designations were identified. The short performance period and use of the DLA pharmaceuticals schedule suggest this delivery order is fulfilling immediate medical supply needs for DOD facilities.
Generated 12/17/23, 8:52 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17 | 7/14/23 |